Results 91 to 100 of about 268,406 (174)

A multi-centre study comparing granulocyte-colony stimulating factors to antibiotics for primary prophylaxis of docetaxel-cyclophosphamide induced febrile neutropenia. [PDF]

Breast, 2021
Clemons M, Fergusson D, Joy AA, Thavorn K, Meza-Junco J, Hiller JP, Mackey J, Ng T, Zhu X, Ibrahim MFK, Sienkiewicz M, Saunders D, Vandermeer L, Pond G, Basulaiman B, Awan A, Pitre L, Nixon NA, Hutton B, Hilton JF, REThinking Clinical Trials (REaCT) investigators.   +20 more
europepmc   +1 more source

Economic Analysis on Adoption of Biosimilar Granulocyte Colony-Stimulating Factors in Patients With Nonmyeloid Cancer at Risk of Febrile Neutropenia Within the Oncology Care Model Framework. [PDF]

JCO Oncol Pract, 2021
Wang W, Li E, Campbell K, McBride A, D'Amato S.   +4 more
europepmc   +1 more source

Impaired granulocyte-macrophage colony-stimulating factor bioactivity accelerates surgical recurrence in ileal Crohn’s disease [PDF]

, 2018
Bonkowski, Erin, Chalk, Claudia, Denson, Lee, Gathungu, Grace, Krumsiek, Julia, Li, Ellen, Newberry, Rodney, Nix, Billy, Rowehl, Leahana, Tian, Xinyu, Trapnell, Bruce, Zhang, Yuanhao, Zhu, Wei   +12 more
core   +2 more sources

Irradiation to Improve the Response to Immunotherapeutic Agents in Glioblastomas. [PDF]

, 2019
PurposeGlioblastoma (GBM) remains an incurable disease despite extensive treatment with surgical resection, irradiation, and temozolomide. In line with many other forms of aggressive cancers, GBM is currently under consideration as a target for ...
Kaprealian, Tania, Lee, Mi-Heon, McBride, William H, Nesseler, Jean Philippe, Nickers, Philippe, Niclou, Simone P, Schaue, Dorthe   +6 more
core  

Efficacy and Safety for the Use of Half-Dosed Pegylated Granulocyte Colony-Stimulating Factors in Preventing Febrile Neutropenia During Chemotherapy in Patients With Malignant Tumors: A Multicenter, Open-Labeled, Single-Arm Phase 2 Trial. [PDF]

Front Oncol, 2022
Mei Q, Li X, Wang R, Qin K, Cheng Y, Cheng W, Dong Y, He Z, Li J, Li M, Tang X, Wang X, Xiao X, Yang B, Zhou Y, Wang R, Huang Q, Hu G, Li J.   +18 more
europepmc   +1 more source

A Survey of Oncologists' Perceptions and Opinions Regarding the Use of Granulocyte Colony-Stimulating Factors. [PDF]

J Cancer Educ, 2020
Hawkins A, Murphy A, McNamara M, Gawade PL, Belani R, Kelsh MA.   +5 more
europepmc   +1 more source

Safety and efficacy of administering reduced doses of pegylated recombinant human granulocyte-colony stimulating factors in patients treated with cisplatin and etoposide for small cell carcinoma: A retrospective study. [PDF]

Thorac Cancer, 2021
Liu C, Hao Y, Wang L, Meng F, Wen F, Zhong D.   +5 more
europepmc   +1 more source

[Colony-stimulating factors].

Mikrobiyoloji bulteni, 1992
The colony-stimulating factors are glycoprotein hormones that regulate the proliferation and differentiation of hematopoietic progenitor cells and the function of mature blood cells. They are claimed to be used in the therapy of some hematologic disorders as well as infectious diseases in recent years.
openaire   +1 more source

Granulocyte and granulocyte-macrophage colony-stimulating factors, their receptors and interleukin-3 levels in newborns

The Turkish Journal of Pediatrics, 1997
Serum levels of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interleukin-3 (IL-3) as well as neutrophil counts were studied on the first, second and fifth days after birth, in order ...
M Coşkun, F Kardelen, N Oygür, L Undar, A Savaş, O Yeğin   +5 more
doaj  

Long-term patient reported outcomes and hematologic toxicity among patients who received Granulocyte-Colony Stimulating Factors during chemotherapy for early breast cancer. [PDF]

Breast, 2021
Lapidari P, Gbenou A, Havas J, Martin E, Pistilli B, Martin AL, Everhard S, Coutant C, Cottu P, Lesur A, Lerebours F, Tredan O, Vanlemmens L, Jouannaud C, Levy C, Rigal O, Fournier M, Andre F, Vaz-Luis I, Di Meglio A.   +19 more
europepmc   +1 more source